Racial/Ethnic Disparities in the Incidence of Epithelial Ovarian Cancer in Florida by Histology, 2001-2015: Analysis of Trends.


Journal

Southern medical journal
ISSN: 1541-8243
Titre abrégé: South Med J
Pays: United States
ID NLM: 0404522

Informations de publication

Date de publication:
07 2021
Historique:
entrez: 3 7 2021
pubmed: 4 7 2021
medline: 15 12 2021
Statut: ppublish

Résumé

Because the population in Florida is 25.6% Hispanic, it is possible to evaluate the influence of race and ethnicity within clinically relevant subgroups of women with epithelial ovarian cancer (EOC), including histology and tumor grade. This study explores racial/ethnic disparities in the incidence of EOC in Florida by histology and tumor grade. This study is an analysis of the Florida Cancer Database System. All incidence EOC cases from 2001 through 2015 were identified. Age-adjusted incidences were calculated and trends modeled by race/ethnicity and histology using Joinpoint and Poisson regression. In total, 80% of the 21,731 women with EOC were White, followed by Hispanic (13.1%) and non-Hispanic Black (7.9%). All races/ethnicities had statistically significant declines in incidence, with non-Hispanic White and non-Hispanic Black women having the steepest declines (annual percentage change -2.5, 95% confidence interval [CI] -5.9 to -2.1 and annual percentage change -2.8, 95% CI -4.8 to -1.5, respectively). A decreased incidence trend across the time period was seen for all subgroups (relative risk 0.97 [95% CI 0.96-0.98], 0.96 [95% CI 0.96-0.99], and 0.98 [95% CI 0.96-0.99] for non-Hispanic White, non-Hispanic Black, and Hispanic). High-grade EOC incidence for all groups did not change with time. We found significant declines in the incidence of EOC for all races/ethnicities, but not for high-grade EOC. The observed incidence decline in Hispanic women differs from previous research. More research is needed to understand women the causes of overall racial/ethnic differences and the decline in EOC.

Identifiants

pubmed: 34215890
doi: 10.14423/SMJ.0000000000001274
pii: SMJ_210074
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-400

Auteurs

Ashly Westrick (A)

From the Department of Public Health Sciences and the Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, and the Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Matthew Schlumbrecht (M)

From the Department of Public Health Sciences and the Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, and the Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Paulo Pinheiro (P)

From the Department of Public Health Sciences and the Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, and the Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

WayWay Hlaing (W)

From the Department of Public Health Sciences and the Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, and the Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Erin Kobetz (E)

From the Department of Public Health Sciences and the Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, and the Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Daniel Feaster (D)

From the Department of Public Health Sciences and the Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, and the Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Raymond Balise (R)

From the Department of Public Health Sciences and the Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, and the Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH